Sun, Sep 21, 2014, 2:22 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

TELIK INC Message Board

SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Last employees being laid off. Office has moved to (See Yahoo Profile) to Sorrento Valley Road in San Diego.
    Most likely, just a mail drop.

  • Reply to

    TheStreet-Telik is Dead!

    by mradequate Jul 2, 2014 1:06 PM

    they solicited over 100 companies and not one was interested in partnering with them, just one company that wants to get on nasdaq came up with this reverse merger deal. I suspect they have all taken a kick back and are now ready to pack it in. 500 million wasted on drugs no body else is interested in.

  • AdamFeuerstein
    Follow
    Telik, Biotech Pariah, Finally Died

    By: Adam Feuerstein Follow | 05/12/14 - 06:24 PM EDT

    Telik never recovered from hiding the premature deaths of ovarian cancer patients treated with its experimental drug Telcyta. Following the serious ethical lapse in 2007, Telik became a biotech pariah, ignored by scientists and investors. Telik's top executives, the husband-and-wife team Michael Wick and Gail Brown, spent the next seven years cashing paychecks paid for by long-gone shareholders.

    With the money finally gone, Telik is also disappearing. On Monday, the company announced a reverse merger with privately held Mabvax Therapeutics. When the deal closes, MabVax stockholders will own 85% of the combined companies, which will also be run by MabVax management and retain the MabVax name. Telik shareholders will own 15% and Wick keeps a seat on the board.

    MabVax is developing cancer vaccines, with two products targeting sarcoma and ovarian cancer enrolling patients in proof-of-concept phase II studies.

TELK
1.100.00(0.00%)Sep 9 3:43 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.